Reversal of multidrug resistance of gastric cancer cells by downregulation of Akt1 with Akt1 siRNA

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 4, 2006, Pages 601-606

  Han, Z ^a   Hong, L ^a   Wu, Kaichun ^a   Han, S ^a   Shen, H ^a   Liu, C ^a   Han, Y ^a   Liu, Z ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AKT1; Apoptosis; Gastric cancer; Multidrug resistance; RNAi

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SMALL INTERFERING RNA; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; EXPRESSION VECTOR; GENE CONSTRUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; RNA, SMALL INTERFERING; STOMACH NEOPLASMS;

EID: 33846472404     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hong L., Zhang Y., Liu N.: Suppression of the cell proliferation in stomach cancer cells by the ZNRD1 gene. Biochem. Biophys. Res. Commun. 321: 611-616, 2004.
2. Litman T., Druley T.E., Stein W.D., Bates S.E.: From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 58: 931-935, 2001.
3. Hong L., Ning X., Shi, Y.: Reversal of multidrug resistance of gastric cancer cells by downregulation of ZNRD1 with ZNRD1 siRNA. Br J Biomed Sci. 61: 206-10, 2004.
4. Hong, L., Zhang, Y., Han, S.: Preparation and Characterization of a Novel Monoclonal Antibody Specific to Human ZNRD1 Protein. Hybrid Hybridomics. 23: 65-68, 2004.
5. Lavie Y., Fiucci G., Liscovitch M.: Upregulation of caveolin in multidrug resistant cancer cells: functional implications. Adv. Drug. Deliv. Rev. 49(3): 317-323, 2001.
6. Hong, L., Piao, Y., Han, Y.: ZNRD1 mediates multidrug resistance of leukemia cells through regulation of P-gp and Bcl-2. Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Mol. Cancer. Ther. 4: 1936-42, 2005.
7. Flaherty K.T.: Chemotherapy and targeted therapy combinations in advanced melanoma. Clin. Cancer Res. 12(7): 2366-2370, 2006.
8. Pino M.S., Shrader M., Baker C.H., Cognetti F., Xiong H.Q., Abbruzzese J.L., McConkey D.J.: Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines. Cancer Res. 66(7):3802-3812, 2006.
9. Zeng Z., Samudio I.J., Zhang W., Estrov Z., Pelicano H., Harris D., Frolova O., Hail N., Chen W., Kornblau S.M., Huang P., Lu Y., Mills G.B., Andreeff M., Konopleva M.: Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia. Cancer Res. 66(7):3737-3746, 2006.
10. Wu K., Crusius J. B. A., Shivanarda S., Fan D.M. and Pena A.S. The immunogenetic and Pathogenesis of gastric cancer. Drugs of Today. 38: 391-417, 2002.
11. Nam S.Y., Lee H.S., Jung G.A., Choi J., Cho S. J., Kim M.K., Kim W.H. and Lee B.L.: Akt/PKB activation in gastric carcinomas correlates with linicopathologic variables and prognosis. APMIS. 11: 1105-1113, 2003.
12. Osaki M., Kase S., Adachi K., Takeda A., Hashimoto K. and Ito H.: Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45. J. Cancer Res. Clin. Oncol. 130: 8-14, 2004.
13. Kang Y. H., Lee H. S. and Kim W. H.: Promoter methylation and silencing of PTEN in gastric carcinoma. Lab. Invest. 82: 285-291, 2002.
14. Hong L., Han Y., Shi R.: ZNRD1 Gene Suppresses Cell Proliferation through Cell Cycle Arrest in G1 Phase. Cancer Biol. Ther. 4(1): 61-65, 2005.
15. Hong, L., Qiao, T., Han, Y.: ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2. Biochem. Cell Biol. 84: 199-206, 2006.
16. Perkins C.L., Fang G., Kim C.N., Bhalla K.N.: The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res. 60: 1645-1653, 2000.
17. Igney F.H., Krammer P.H.: Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer. 2: 277-288, 2002.
18. Sattler M., Liang H., Nettesheim D. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science. 275(5302): 983-986, 1997.
19. Reed J.C.: Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17: 2941-2953, 1999.